Clinical Trials on Primary Hyperoxaluria Type 2 (PH2) in Czechia
Total 380 results
-
Institute for Clinical and Experimental MedicineCompleted
-
Charles University, Czech RepublicCompleted
-
University Hospital OstravaMinistry of Health, Czech Republic; Regional Council of the Moravian-Silesian...CompletedCritical Lower Limb Ischemia | Type-2 Diabetes MellitusCzechia
-
Institute for Clinical and Experimental MedicineUnknown
-
Charles University, Czech RepublicCompleted
-
University of OstravaInstitute for Clinical and Experimental Medicine; Vitkovice HospitalActive, not recruiting
-
Charles University, Czech RepublicUniversity Ghent; University of Leicester; St George's, University of London; University...RecruitingPreDiabetes | Type 2 DiabetesCzechia
-
GT Metabolic Solutions, Inc.Recruiting
-
Institute for Clinical and Experimental MedicineRecruitingType 2 Diabetes Treated With InsulinCzechia
-
Astellas Pharma IncCompleted
-
University Hospital OstravaUniversity of Ostrava; Vitkovice Hospital, Ostrava, Czech RepublicCompleted
-
Institute for Clinical and Experimental MedicineUnknownInsulin Resistance | Chronic Heart FailureCzechia
-
Charles University, Czech RepublicCompleted
-
University Hospital, MontpellierCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1France, Italy, Czechia
-
Charles University, Czech RepublicCompletedType 2 Diabetes Mellitus With Features of Insulin ResistanceCzech Republic
-
Institute for Clinical and Experimental MedicineCompletedType 2 Diabetes | Postprandial Oxidative StressCzech Republic
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Slovakia, Czechia
-
Vitadio s.r.o.University Hospital OlomoucCompletedObesity | Diabetes Mellitus, Type 2 | Insulin Resistance | Prediabetic StateCzechia
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesHungary, Czechia
-
Institute for Clinical and Experimental MedicineCompletedInsulin Resistance | Type 2 DiabetesCzech Republic
-
Institute for Clinical and Experimental MedicineMinistry of Health, Czech RepublicCompletedInsulin Resistance | Type 2 DiabetesCzech Republic
-
Charles University, Czech RepublicNot yet recruitingRecurrence | Cervical Intraepithelial Neoplasia Grade 2/3Czechia
-
Digma Medical Ltd.RecruitingDiabetes Mellitus, Type 2Israel, Czechia, Spain
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Italy, Spain, Sweden, Canada, Bulgaria, Poland, Czechia
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Japan, Czechia, Hungary, Poland, Spain
-
Institute of Hematology and Blood Transfusion,...CZECRIN - Czech Clinical Research Infrastructure NetworkCompletedNewly Diagnosed | Lymphoblastic Leukemia, Acute, Adult | Ph Negative ALLCzechia
-
Institute for Clinical and Experimental MedicinePoliklinika Agel, Dopravni zdravotnictvi a.s.RecruitingHealthy | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Functional Dyspepsia | GastroparesisCzechia, Slovakia
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesPoland, Slovakia, Czechia
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Bulgaria, Czech Republic, Hungary, Poland
-
ChemoCentryxCompletedType 2 Diabetes MellitusGermany, New Zealand, Hungary, Czechia, Australia
-
Institute of Hematology and Blood Transfusion,...CZECRIN - Czech Clinical Research Infrastructure NetworkSuspendedNewly Diagnosed | Acute Lymphoblastic Leukemia, Adult | Ph+ ALLCzechia
-
University Hospital OstravaCompletedPrimary Hyperparathyroidism | Parathyroid Diseases | Thyroid Disease | Parathyroid AdenomaCzechia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czechia, Puerto Rico, Poland, Mexico
-
Aptabio Therapeutics, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetic Nephropathies | Nephropathy, DiabeticBulgaria, Czechia, Hungary, Serbia
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCzech Republic
-
Institute for Clinical and Experimental MedicineCompletedDiabetes Mellitus, Type 2Czech Republic
-
TME Pharma AGCompletedType 2 Diabetes Mellitus | AlbuminuriaPoland, Germany, Romania, Hungary, Czech Republic
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusCzechia, Hungary, United States, Mexico, Germany, Austria, Israel, Puerto Rico, Spain
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCzech Republic
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlGermany, Slovakia, Czechia, Hungary, Poland
-
Novartis PharmaceuticalsTerminatedCardiovascular Disease | Type 2 Diabetes MellitusSpain, China, United States, Belgium, Colombia, South Africa, Italy, United Kingdom, Germany, Hungary, Japan, Taiwan, Turkey, Netherlands, Greece, Switzerland, Austria, France, Thailand, Argentina, Canada, Singapore, Lithuania, Sweden, ... and more
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic